<p>Teriparatide is a parathyroid hormone analog, (PTH 1-34), indicated for:</p>

<ul>
	<li>Treatment of postmenopausal women with osteoporosis at high risk for fracture.</li>
	<li>Increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture.</li>
	<li>Treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy at high risk for fracture.</li>
</ul>